Investigating the role of acute and repeated stress on remote ischemic preconditioning-induced cardioprotection

Document Type : Original Article


Department of Pharmaceutical Sciences and Drug Research Punjabi University, Patiala, India


Objective(s): To study the effect of acute and repeated stress on cardioprotection-induced by remote ischemic preconditioning (RIPC).
Materials and Methods: RIPC was induced by giving 4 short cycles of ischemia and reperfusion, each consisting of five min. The Langendorff’s apparatus was used to perfuse the isolated rat hearts by subjecting the hearts to global ischemia of 30 min and reperfusion of 120 min. The coronary effluent was collected to measure the levels of lactate dehydrogenase (LDH) and creatine kinase (CK) for the assessment of injury to the myocardium. Myocardial infarct size was measured by the use of triphenyl tetrazolium chloride. Acute stress was induced by subjecting the animals to cold immersion stress for 5 min. However, in the case of stress adaptation, rats were exposed to a homotypic stressor (cold-water immersion stress) each of 5 min duration for five consecutive days.
Results: RIPC demonstrated a significant decrease in ischemia-reperfusion-induced myocardial injury in terms of decrease in LDH, CK, and infarct size. However, acute stress for five minutes prior to RIPC significantly abolished its cardioprotective effects. Exogenous administration of adenosine restored RIPC-induced cardioprotective effects in the presence of acute stress. On repeated stress exposure for 5 days, stress adaptation was noted, and there was no effect of repeated stress exposure on RIPC-induced cardioprotection. However, the cardioprotective effects of adenosine were absent in the case of rats subjected to repeated episodes of stress.
Conclusion: Acute stress, but not repeated stress exposure, may alter the release of adenosine during RIPC, which may be manifested in the form of reduced cardioprotection during ischemic-reperfusion injury.


1. Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat Med 2011; 17:1391-1401
2. Murry CE, Jennings RB, Reimer KA. Pre-conditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136.
3. McCully JD, Toyoda Y, Uematsu M, Stewart RD, Levitsky S. Adenosine-enhanced ischemic preconditioning: adenosine receptor involvement during ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2001; 280:591-602.
4. Przyklenk K. Reduction of myocardial infarct size with ischemic “conditioning”: physiologic and technical considerations. Anesth Analg 2013; 117:891-901.
5. Randhawa PK, Jaggi AS. TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardio protection. Eur J Pharmacol 2015; 746:180–185.
6. Randhawa PK, Jaggi AS. Gadolinium and ruthenium red attenuate remote hind limb preconditioning-induced cardioprotection: possible role of TRP and especially TRPV channels. Naunyn Schmiede Arch Pharmacol 2016; 389:887–896.
7. Crimi G, Pica S, Raineri C, Bramucci E, De Ferrari GM, Klersy C et al. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. JACC Cardiovasc Interv 2013; 6:1055-1063.
8. Gao F, Liang Y, Wang X, Lu Z, Li L, Zhu S et al. TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac 3Hypertrophy and Fibrosis through PPAR-δ Upregulation. PPAR Res 2014; 2014:491963.
9. Zhu SB, Liu Y, Zhu Y, Yin GL, Wang RP, Zhang Y et al. Remote preconditioning, perconditioning, and postconditioning: a comparative study of their cardio-protective properties in rat models. Clinics (Sao Paulo) 2013; 68:263-268.
10. Zaugg M, Schaub MC. Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil 2003; 24:219-249.
11. Fudickar A, Kunath S, Voß D, Siggelkow M, Cavus E, Steinfath M et al. Effect of ischemic and pharmacological preconditioning of lower limb muscle tissue on tissue oxygenation measured by near-infrared spectroscopy--a pilot study. BMC Anesthesiol 2014; 14:54-63.
12. Ali N, Rizwi F, Iqbal A, Rashid A. Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. J Coll Physicians Surg Pak 2010; 20:427-431.
13. Lee KS, Lim BV, Jang MH, Shin MC, Lee TH, Kim YP et al. Hypothermia inhibits cell proliferation and nitric oxide synthase expression in rats. Neurosci Lett 2002; 329:53-56.
14. McCafferty K, Forbes S, Thiemermann C, Yaqoob MM. The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. Dis Model Mech 2014; 7:1321-1333.
15. Voucharas C, Lazou A, Triposkiadis F, Tsilimingas N. Remote preconditioning in normal and hypertrophic rat hearts. J Cardio Thorac Surg 2011; 6:34-40.
16. Cleveland JC Jr, Meldrum DR, Cain BS, Banerjee A, Harken AH. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 1997; 96:29-32.
17. Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg 2014; 147:376-382.
18. Musazzi L, Milanese M, Farisello P, Zappettini S, Tardito D, Barbiero VS, et al. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/ frontal cortex: the dampening action of antidepressants. PLoS ONE 2010; 1:8566.
19. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25:33–39.
 20. Livingston M, Heaney LG, Ennis M. Adenosine, inflammation and asthma--a review. Inflamm Res 2004; 53:171-178.
21. Lankford AR, Yang JN, Rose’Meyer R, French BA, Matherne GP, Fredholm BB et al. Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart CircPhysiol 2006; 290:469-473.
22. Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine: physiology, pharmacology, and clinical applications. JACC Cardiovasc Interv 2014; 7:581-591.
23. Singh L, Kulshrestha R, Singh N, Jaggi AS. Mechanisms involved in adenosine pharmacological preconditioning-induced cardioprotection. Korean J Physiol Pharmacol 2018; 22:225-234.
24. Randhawa PK, Jaggi AS. Investigating the involvement of TRPV1 ion channels in remote hind limb preconditioning-induced cardioprotection in rats. NaunynSchmiede. Arch Pharmacol 2017; 390:117–126.
25. Agrawal A, Jaggi AS, Singh N. Pharmacological investigations on adaptation in rats subjected to cold-water immersion stress. Physiol Behav 2011; 103:321-329.
26. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC et al. Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101:593–600.
27. Ito Y, Tamura I. Age-related changes in collagen, laminin and tenascin in the infant rat submandibular gland. J Osaka Dent Univ 1997; 31:19-27.
28. Jaggi AS, Singh M, Sharma A, Singh D, Singh N, Cardioprotective effects of mast cell modulators in ischemia-reperfusion-induced injury in rats. Methods Find Exp Clin Pharmacol 2007; 29:593-600.
29. Diwan V, Jaggi A.S, Singh M, Singh N, Singh D. Possible involvement of erythropoietin in remote renal preconditioning-induced cardioprotection in rats. J Cardiovasc Pharmacol 2008; 51:126–130.
30. King JA. A routine method for estimation of lactate dehydrogenase activity. J Med Lab Tech 1959; 16:291–332.
31. Randhawa PK, Jaggi AS. TRPV1 channels in cardiovascular system: a double-edged sword? Int J Cardiol 2017; 228:103–113.
32. Sharma R, Randhawa PK, Singh N, Jaggi AS. Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection. Naunyn Schmiedebergs Arch. Pharmacol 2016; 389:1–9.
33. Singh H, Kumar M, Singh N, Jaggi AS. Late phases of cardioprotection during remote ischemic preconditioning and adenosine preconditioning involve activation of neurogenic pathway. J Cardiovasc Pharmacol 2019; 73:63-69.
34. Márquez MF, Sobrino A, Vallejo M, Hermosillo AG, Guzmán C, Férez-Santander SM et al. Diagnostic evaluation of cardiovascular autonomic function in patients with diabetes mellitus. Rev Invest Clin 2003; 55:606-615.
35. Loubani M, Fowler A, Standen NB, Galiñanes M. The effect of gliclazide and glibenclamide on preconditioning of the human myocardium. Eur J Pharmacol 2005; 515:142-149.
36. Kottenberg E, Thielmann M, Kleinb ongard P, Frey UH, Heine T, Jakob H et al. Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonyl urea-treated diabetics undergoing coronary revascularisation. Acta Anaesthesiol Scand 2014; 147:453-462.
37. Zhang J, Liu XB, Cheng C, Xu DL, Lu QH, Ji XP. Rho-kinase inhibition is involved in the activation of PI3-kinase/Akt during ischemic-preconditioning-induced cardiomyocyte apoptosis. Int J Clin Exp Med 2014; 7:4107-4114.